Next-Generation Liposomal Coenzyme Q 10 : From Formulation to Clinical Evidence via Metazome Technology for Improved Stability and Enhanced Oral Absorption

Key Points

• The aim is to explore the benefits of a next-generation liposomal formulation of coenzyme Q 10 to enhance its stability and oral absorption.
• Developed a novel liposomal formulation using Metazome technology
• Evaluated the stability of the formulation
• Analyzed oral absorption in relevant models
• Assessed clinical efficacy against cardiovascular and neurodegenerative disorders
• The liposomal formulation showed significantly improved stability compared to traditional methods
• Enhanced oral absorption was observed in test models
• Clinical outcomes indicated potential benefits in managing various disorders